English | PDF | 2007 | 405 Pages | ISBN : 0387366024
Glycerophospholipids in Brain: Phospholipases A2 in Neurological Disorders provides a synthesis of material on the metabolism of phospholipids in the brain which has previously only been available in a scattered number of original papers and reviews. Here, the research of over 25 years is collected in one volume from two of the leading researchers in the field— Akhlaq A. Farooqui and Lloyd A. Horrocks
Glycerophospholipids in Brain: Phospholipases A2 in Neurological Disorders comprehensively describes
cutting-edge information on the properties and roles of phospholipases A2 in the central nervous system
release by phospholipases A2 of second messengers (arachidonic acid, docosahexaenoic acid, and lysophospholipid) from neural membrane phospholipids and their neurochemical effects on brain metabolism and function
involvement of phospholipases A2 in neurological and neuropsychiatric disorders, and the use of phospholipase A2 inhibitors for the treatment of diseases associated with altered phospholipid metabolism
methods for the assays of phospholipases A2 and their clinical significance. Students will benefit from it as a supplement for a range of neuroscience courses. Clinicians will find it invaluable as well for understanding molecular aspects of neurodegeneration in acute neural trauma (stroke) and neurodegenerative diseases (Alzheimer disease) that are mediated by phospholipases A2.
About the Authors
Akhlaq A. Farooqui and Lloyd A. Horrocks are leaders in the fields of phospholipid metabolism and phospholipases A2 in brain. They have published cutting edge research on phospholipases A2 and their involvement in neurological disorders in brain tissue. In collaboration with Dr. Yutaka Hirashima, they have discovered a plasmalogen-selective phospholipase A2 in brain. Lloyd A. Horrocks is the founding editor of Molecular and Chemical Neuropathology and has edited seven books.
